The Current and Future State of China's Pharmaceutical Industry

The report is part of the individual study made to complement the Group Management Project with an examination of China’s current and future role in the global pharmaceutical industry. The report represents the individual component of the group project by providing an understanding of the rising com...

Full description

Bibliographic Details
Main Author: Goh, Ming Tze
Format: Dissertation (University of Nottingham only)
Language:English
Published: 2010
Online Access:https://eprints.nottingham.ac.uk/23850/
_version_ 1848792645263949824
author Goh, Ming Tze
author_facet Goh, Ming Tze
author_sort Goh, Ming Tze
building Nottingham Research Data Repository
collection Online Access
description The report is part of the individual study made to complement the Group Management Project with an examination of China’s current and future role in the global pharmaceutical industry. The report represents the individual component of the group project by providing an understanding of the rising competition from pharmaceutical companies like China that is becoming the main source of pharmaceutical products in the European Union (‘EU’) region as outlined in the exploration of future scenarios for the region in the year 2030. Through the analysis of the current state of China’s pharmaceuticals industry, future businesses within the generics market in the EU can determine the best strategic decisions to make with consideration of the presence of the Chinese companies operating within the EU environment in the coming years.
first_indexed 2025-11-14T18:47:42Z
format Dissertation (University of Nottingham only)
id nottingham-23850
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T18:47:42Z
publishDate 2010
recordtype eprints
repository_type Digital Repository
spelling nottingham-238502022-03-21T16:07:47Z https://eprints.nottingham.ac.uk/23850/ The Current and Future State of China's Pharmaceutical Industry Goh, Ming Tze The report is part of the individual study made to complement the Group Management Project with an examination of China’s current and future role in the global pharmaceutical industry. The report represents the individual component of the group project by providing an understanding of the rising competition from pharmaceutical companies like China that is becoming the main source of pharmaceutical products in the European Union (‘EU’) region as outlined in the exploration of future scenarios for the region in the year 2030. Through the analysis of the current state of China’s pharmaceuticals industry, future businesses within the generics market in the EU can determine the best strategic decisions to make with consideration of the presence of the Chinese companies operating within the EU environment in the coming years. 2010-09-17 Dissertation (University of Nottingham only) NonPeerReviewed application/pdf en https://eprints.nottingham.ac.uk/23850/1/GMT_Individual2010.pdf Goh, Ming Tze (2010) The Current and Future State of China's Pharmaceutical Industry. [Dissertation (University of Nottingham only)] (Unpublished)
spellingShingle Goh, Ming Tze
The Current and Future State of China's Pharmaceutical Industry
title The Current and Future State of China's Pharmaceutical Industry
title_full The Current and Future State of China's Pharmaceutical Industry
title_fullStr The Current and Future State of China's Pharmaceutical Industry
title_full_unstemmed The Current and Future State of China's Pharmaceutical Industry
title_short The Current and Future State of China's Pharmaceutical Industry
title_sort current and future state of china's pharmaceutical industry
url https://eprints.nottingham.ac.uk/23850/